Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom
at The Street - Wed Jul 23, 7:05PM CDT
Should investors settle for average results? Absolutely not, Cramer says.
Final Glance: Biotechnology companies
AP - Wed Jul 23, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Will Generics Eat Into Eli Lilly's (LLY) Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 3:34PM CDT
Eli Lilly and Company (LLY) is set to report second-quarter 2014 results on Jul 24.
Earnings Preview: Bristol-Myers Squibb and Celgene Corporation
George Budwell, The Motley Fool - Motley Fool - Wed Jul 23, 1:00PM CDT
Most health care stocks have been experiencing a roller coaster ride so far this year. While the underlying cause(s) of this volatility is likely multifaceted in nature, I think a fair amount is attributable to the uncertain outlook regarding some of...
S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade
at Investor's Business Daily - Wed Jul 23, 12:29PM CDT
Stocks added gains Wednesday afternoon as the S&P 500 tried to hold on to a new high. The Nasdaq rose 0.3%, while the S&P 500 tacked on 0.1%. The Dow Jones industrial average diverged, slipping 0.2%. Volume in the stock market today was running...
Midday Glance: Biotechnology companies
AP - Wed Jul 23, 12:25PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Biogen's Q2 Earnings Surpass Expectations, Tecfidera Shines - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jul 23, 12:20PM CDT
Biogen (BIIB) upped its earnings and revenue guidance significantly on the strong performance of Tecfidera and the AIFA agreement.
Video: Biogen Trounces Q2 Estimates On Tecfidera
at Investor's Business Daily - Wed Jul 23, 10:56AM CDT
Big-cap biotech Biogen Idec (BIIB) soundly beat analysts' Q2 expectations and substantially raised its guidance early Wednesday, sending shares up more than 11% in midday trading in the stock market today to near 338, a four-month high. Biogen's Q2...
Celgene (CELG) Is Today's Momo Momentum Stock
at The Street - Wed Jul 23, 8:50AM CDT
Trade-Ideas LLC identified Celgene (CELG) as a momo momentum candidate
'Fast Money' Recap: Apple and Microsoft Earnings in the Spotlight
at The Street - Wed Jul 23, 4:00AM CDT
The trading panel discussed whether Apple's quarter was good enough, how PCs are benefiting Microsoft and whether it's time to start buying auto stocks.
Celgene Set to Possibly Pullback After Yesterday's Rally of 1.58%
Comtex SmarTrend(R) - Tue Jul 22, 4:16PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $85.87 to a high of $87.12. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $86.19 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Celgene (CELG) Set to Beat Earnings Estimates on Strong Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 3:55PM CDT
Celgene Corporation (CELG) is set to report second quarter 2014 results on Jul 24 before market opens.
Will Biogen Idec Inc. (BIIB) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 12:50PM CDT
Biogen Idec Inc. (BIIB) is scheduled to report its second-quarter 2014 results before the opening bell on Jul 23.
Alexion, 3 Other Top Biotechs Reporting Earnings
at Investor's Business Daily - Tue Jul 22, 11:42AM CDT
The four highest-rated of the market's seven big-cap biotechs are set to report second-quarter earnings this week, each with its own unique storyline. Biogen Idec (BIIB), the subject of Tuesday's New America, will be first to report before the open...
Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 10:20AM CDT
Gilead Sciences (GILD) is set to report second quarter 2014 results on Jul 23 after the market closes.
Early Glance: Biotechnology companies
AP - Tue Jul 22, 10:16AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Buy 100 Stocks Loved by Insiders
Selena Maranjian, The Motley Fool - Motley Fool - Tue Jul 22, 9:40AM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to invest in companies where insiders have been snapping up shares but don't have the time to track them down, the Guggenheim Insider...